Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (10): 936-940.DOI: 10.3969/j.issn.1673-8640.2023.10.006
Previous Articles Next Articles
QIAN Linyu1, LIANG Weifang1(), TANG Sichen2
Received:
2021-12-20
Revised:
2023-05-10
Online:
2023-10-30
Published:
2023-12-18
CLC Number:
QIAN Linyu, LIANG Weifang, TANG Sichen. Determination and clinical significance of NLRP3,CTRP6 and IL-1β in patients with gestational diabetes mellitus[J]. Laboratory Medicine, 2023, 38(10): 936-940.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.10.006
组别 | 例数 | 年龄/岁 | 孕周/周 | 孕次/次 | BMI/ (kg/m2) | TG/ (mmol/L) | TC/ (mmol/L) | LDL-C/ (mmol/L) | HDL-C/ (mmol/L) |
---|---|---|---|---|---|---|---|---|---|
GDM组 | 145 | 28.7±4.9 | 27.9±1.7 | 1.74±0.56 | 26.17±1.94 | 2.51±0.39 | 4.61±0.74 | 2.46±0.29 | 1.43±0.28 |
对照组 | 145 | 28.1±4.2 | 27.6±1.3 | 1.68±0.52 | 25.94±1.87 | 2.60±0.42 | 4.49±0.78 | 2.51±0.32 | 1.36±0.38 |
t值 | 1.121 | 1.688 | 0.945 | 1.028 | 1.891 | 1.344 | 1.394 | 1.786 | |
P值 | 0.264 | 0.093 | 0.345 | 0.305 | 0.060 | 0.180 | 0.164 | 0.075 |
组别 | 例数 | 年龄/岁 | 孕周/周 | 孕次/次 | BMI/ (kg/m2) | TG/ (mmol/L) | TC/ (mmol/L) | LDL-C/ (mmol/L) | HDL-C/ (mmol/L) |
---|---|---|---|---|---|---|---|---|---|
GDM组 | 145 | 28.7±4.9 | 27.9±1.7 | 1.74±0.56 | 26.17±1.94 | 2.51±0.39 | 4.61±0.74 | 2.46±0.29 | 1.43±0.28 |
对照组 | 145 | 28.1±4.2 | 27.6±1.3 | 1.68±0.52 | 25.94±1.87 | 2.60±0.42 | 4.49±0.78 | 2.51±0.32 | 1.36±0.38 |
t值 | 1.121 | 1.688 | 0.945 | 1.028 | 1.891 | 1.344 | 1.394 | 1.786 | |
P值 | 0.264 | 0.093 | 0.345 | 0.305 | 0.060 | 0.180 | 0.164 | 0.075 |
组别 | 例数 | CTRP6/ (μg/L) | NLRP3/ (pg/mL) | IL-1β/ (pg/mL) | FINS/(mU/L) | HbA1c/% | FPG/(mmol/L) | HOMA-β | HOMA-IR |
---|---|---|---|---|---|---|---|---|---|
GDM组 | 145 | 506.43±119.52 | 236.80±57.14 | 27.21±6.74 | 10.59±1.42 | 6.28±0.61 | 5.49±0.31 | 35.98±9.39 | 4.34±0.61 |
对照组 | 145 | 391.76±101.98 | 156.20±32.12 | 17.69±4.24 | 7.31±1.54 | 4.63±0.69 | 4.47±0.22 | 61.08±12.15 | 1.98±0.54 |
t值 | 8.789 | 14.817 | 14.397 | 18.855 | 21.573 | 32.311 | 19.683 | 34.883 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | CTRP6/ (μg/L) | NLRP3/ (pg/mL) | IL-1β/ (pg/mL) | FINS/(mU/L) | HbA1c/% | FPG/(mmol/L) | HOMA-β | HOMA-IR |
---|---|---|---|---|---|---|---|---|---|
GDM组 | 145 | 506.43±119.52 | 236.80±57.14 | 27.21±6.74 | 10.59±1.42 | 6.28±0.61 | 5.49±0.31 | 35.98±9.39 | 4.34±0.61 |
对照组 | 145 | 391.76±101.98 | 156.20±32.12 | 17.69±4.24 | 7.31±1.54 | 4.63±0.69 | 4.47±0.22 | 61.08±12.15 | 1.98±0.54 |
t值 | 8.789 | 14.817 | 14.397 | 18.855 | 21.573 | 32.311 | 19.683 | 34.883 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
项目 | FINS | HbA1c | FPG | HOMA-β | HOMA-IR |
---|---|---|---|---|---|
CTRP6 | |||||
r值 | 0.391 | 0.334 | 0.429 | -0.226 | 0.338 |
P值 | <0.001 | <0.001 | <0.001 | 0.014 | <0.001 |
NLRP3 | |||||
r值 | 0.335 | 0.317 | 0.372 | -0.354 | 0.228 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | 0.012 |
IL-1β | |||||
r值 | 0.394 | 0.422 | 0.347 | -0.359 | 0.325 |
P值 | 0.022 | 0.018 | 0.009 | <0.001 | <0.001 |
项目 | FINS | HbA1c | FPG | HOMA-β | HOMA-IR |
---|---|---|---|---|---|
CTRP6 | |||||
r值 | 0.391 | 0.334 | 0.429 | -0.226 | 0.338 |
P值 | <0.001 | <0.001 | <0.001 | 0.014 | <0.001 |
NLRP3 | |||||
r值 | 0.335 | 0.317 | 0.372 | -0.354 | 0.228 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | 0.012 |
IL-1β | |||||
r值 | 0.394 | 0.422 | 0.347 | -0.359 | 0.325 |
P值 | 0.022 | 0.018 | 0.009 | <0.001 | <0.001 |
组别 | 例数 | CTRP6/ (μg/L) | NLRP3/(pg/mL) | IL-1β/(pg/mL) | FINS/(mU/L) | HbA1c/% | FPG/(mmol/L) | HOMA-β | HOMA-IR |
---|---|---|---|---|---|---|---|---|---|
不良妊娠组 | 40 | 619.73±119.61 | 284.35±62.74 | 33.67±4.65 | 11.42±0.48 | 6.97±0.23 | 5.76±0.18 | 33.14±5.61 | 4.96±0.18 |
正常妊娠组 | 105 | 463.27±87.17 | 218.72±42.98 | 24.74±5.71 | 10.27±0.78 | 6.01±0.35 | 5.37±0.20 | 37.08±6.36 | 4.10±0.33 |
t值 | 8.673 | 7.275 | 8.824 | 10.699 | 19.242 | 10.778 | 3.440 | 20.010 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.001 | <0.001 |
组别 | 例数 | CTRP6/ (μg/L) | NLRP3/(pg/mL) | IL-1β/(pg/mL) | FINS/(mU/L) | HbA1c/% | FPG/(mmol/L) | HOMA-β | HOMA-IR |
---|---|---|---|---|---|---|---|---|---|
不良妊娠组 | 40 | 619.73±119.61 | 284.35±62.74 | 33.67±4.65 | 11.42±0.48 | 6.97±0.23 | 5.76±0.18 | 33.14±5.61 | 4.96±0.18 |
正常妊娠组 | 105 | 463.27±87.17 | 218.72±42.98 | 24.74±5.71 | 10.27±0.78 | 6.01±0.35 | 5.37±0.20 | 37.08±6.36 | 4.10±0.33 |
t值 | 8.673 | 7.275 | 8.824 | 10.699 | 19.242 | 10.778 | 3.440 | 20.010 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.001 | <0.001 |
项目 | AUC(95%CI) | 最佳临界值 | 敏感性/% | 特异性/% | P值 |
---|---|---|---|---|---|
CTRP6 | 0.846(0.771~0.921) | 644.21 μg/L | 60.1 | 96.2 | <0.001 |
NLRP3 | 0.802(0.716~0.889) | 300.34 pg/mL | 57.5 | 94.3 | <0.001 |
IL-1β | 0.871(0.813~0.926) | 28.74 pg/mL | 90.0 | 71.4 | <0.001 |
FINS | 0.663(0.616~0.724) | 10.79 mU/L | 61.8 | 79.4 | <0.001 |
HbA1c | 0.691(0.629~0.738) | 6.76% | 77.3 | 67.4 | <0.001 |
FPG | 0.659(0.603~0.705) | 5.41 mmol/L | 71.6 | 68.2 | <0.001 |
HOMA-β | 0.677(0.622~0.763) | 33.98 | 66.5 | 69.6 | <0.001 |
HOMA-IR | 0.658(0.596~0.717) | 4.72 | 67.2 | 71.0 | <0.001 |
CTRP6+NLRP3+IL-1β | 0.931(0.891~0.974) | 0.931 | 90.2 | 80.7 | <0.001 |
项目 | AUC(95%CI) | 最佳临界值 | 敏感性/% | 特异性/% | P值 |
---|---|---|---|---|---|
CTRP6 | 0.846(0.771~0.921) | 644.21 μg/L | 60.1 | 96.2 | <0.001 |
NLRP3 | 0.802(0.716~0.889) | 300.34 pg/mL | 57.5 | 94.3 | <0.001 |
IL-1β | 0.871(0.813~0.926) | 28.74 pg/mL | 90.0 | 71.4 | <0.001 |
FINS | 0.663(0.616~0.724) | 10.79 mU/L | 61.8 | 79.4 | <0.001 |
HbA1c | 0.691(0.629~0.738) | 6.76% | 77.3 | 67.4 | <0.001 |
FPG | 0.659(0.603~0.705) | 5.41 mmol/L | 71.6 | 68.2 | <0.001 |
HOMA-β | 0.677(0.622~0.763) | 33.98 | 66.5 | 69.6 | <0.001 |
HOMA-IR | 0.658(0.596~0.717) | 4.72 | 67.2 | 71.0 | <0.001 |
CTRP6+NLRP3+IL-1β | 0.931(0.891~0.974) | 0.931 | 90.2 | 80.7 | <0.001 |
[1] | 张淳义, 倪颖华, 季鑫, 等. 妊娠期糖尿病患者糖化血红蛋白和糖化白蛋白水平与新生儿体重的相关性[J]. 检验医学, 2017, 32(3):165-168. |
[2] |
ZHUANG Y, ZHANG J, LI Y, et al. B lymphocytes are predictors of insulin resistance in women with gestational diabetes mellitus[J]. Endocr Metab Immune Disord Drug Targets, 2019, 19(3):358-366.
DOI PMID |
[3] |
BRAGA F O, NEGRATO C A, MATTA M F B D, et al. Relationship between inflammatory markers,glycated hemoglobin and placental weight on fetal outcomes in women with gestational diabetes[J]. Arch Endocrinol Metab, 2019, 63(1):22-29.
DOI URL |
[4] |
ZHUO X, TIAN Y, WEI Y, et al. Flavone of Hippophae(H-flavone) lowers atherosclerotic risk factors via upregulation of the adipokine C1q/tumor necrosis factor-related protein 6(CTRP6) in macrophages[J]. Biosci Biotechnol Biochem, 2019, 83(11):2000-2007.
DOI URL |
[5] |
WANG M, TANG X, LI L, et al. C1q/TNF-related protein-6 is associated with insulin resistance and the development of diabetes in Chinese population[J]. Acta Diabetol, 2018, 55(12):1221-1229.
DOI PMID |
[6] |
GAO L, LU G, LU Y, et al. Diabetes aggravates acute pancreatitis possibly via activation of NLRP3 inflammasome in db/db mice[J]. Am J Transl Res, 2018, 10(7):2015-2025.
DOI PMID |
[7] | 中华医学会妇产科学分会产科学组, 中华医学会围产医学分会妊娠合并糖尿病协作组. 妊娠合并糖尿病诊治指南(2014)[J]. 中华妇产科杂志, 2014, 49(8):561-569. |
[8] | 崔倩卫, 冷吉燕, 卜丽梅, 等. 高血压伴胰岛素抵抗患者血清脂联素水平与动脉粥样硬化的相关性研究[J]. 中国老年学杂志, 2011, 31(11):1959-1961. |
[9] |
MCLNTYRE H D, CATALANO P, ZHANG C, et al. Gestational diabetes mellitus[J]. Nat Rev Dis Primers, 2019, 5:47.
DOI PMID |
[10] |
ZHENG W, ZHANG S, MA H, et al. C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury[J]. J Cell Biochem, 2019, 120(6):10748-10755.
DOI URL |
[11] |
WU W, ZHANG J, ZHAO C, et al. Lentivirus-mediated CTRP6 silencing ameliorates diet-induced obesity in mice[J]. Exp Cell Res, 2018, 367(1):15-23.
DOI PMID |
[12] |
LACROIX M, LIZOTTE F, HIVERT M F, et al. Calcifediol decreases interleukin-6 secretion by cultured human trophoblasts from GDM pregnancies[J]. J Endocr Soc, 2019, 3(11):2165-2178.
DOI PMID |
[13] |
DING T, WANG S, ZHANG X, et al. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome[J]. Phytomedicine, 2018, 41:45-53.
DOI PMID |
[14] | LEGRAND-POELS S, ESSER N, L'HOMME L, et al. Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes[J]. Biochem Pharmacol, 2014, 92(1):131-141. |
[15] | 夏红飞, 郝艳红, 彭景楩. 妊娠大鼠子宫和胎盘IL-1β表达及IFN-γ对其表达的影响[J]. 动物学报, 2004, 50(1):48-54. |
[16] | 赵璐, 杨华, 刘国艳. NLR家族Pyrin域蛋白3炎症小体与妊娠的研究进展[J]. 国际妇产科学杂志, 2021, 48(3):255-258. |
[1] | CHEN Hui, CHEN Guanghui, LIANG Yingliang, WANG Wandang, YIN Zhijun. Screening hub genes and diagnostic analysis of gestational diabetes mellitus based on GEO database [J]. Laboratory Medicine, 2023, 38(3): 276-281. |
[2] | KE Qiulei, HUANG Jing, CHEN Aizheng, SONG Yanfeng, SU Xiaofeng. Subgingival flora and the relations between periodontal health indexes and risk of periodontal disease in patients with GDM [J]. Laboratory Medicine, 2023, 38(2): 163-166. |
[3] | WANG Lingling, REN Chunli. Correlation of MTHFR gene C677T polymorphism and blood lipid levels with GDM [J]. Laboratory Medicine, 2022, 37(6): 543-546. |
[4] | ZHANG Xiaoqin, ZHOU Yulan, FU Zhumei, HAN Xuexue, ZHAN Jie. Relationship of mtDNA T16189C mutation and gestational diabetes mellitus [J]. Laboratory Medicine, 2022, 37(5): 413-416. |
[5] | LE Jiangman, LI Tianyuan, TAN Meiyu, WANG Yajie, ZHOU Lida, SHU Jie, WU Jiaoxiang, SUN Hanxiao, XUAN Binbin, CAI Xushan, SHENG Huiming. Correlation of gestational diabetes mellitus with plasma TMAO [J]. Laboratory Medicine, 2021, 36(8): 795-799. |
[6] | WANG Yu, ZHANG Wenwen, LIU Meiling, LIU Xiaojuan. Relationship between AFP,free-βHCG,uE3 and GDM in the second trimester of pregnancy [J]. Laboratory Medicine, 2021, 36(8): 828-832. |
[7] | ZHOU Lifang, PAN Shun, TANG Zhenhua. Application of Raman spectroscopy in the diagnosis of gestational diabetes mellitus [J]. Laboratory Medicine, 2021, 36(3): 313-317. |
[8] | XU Zhen, MA Lijuan, WU Siyi, WANG Yan, JIA Keke. Predictive role of serum fibronectin level in the second trimester of pregnancy for patients with gestational diabetes mellitus complicated with preeclampsia [J]. Laboratory Medicine, 2020, 35(6): 561-565. |
[9] | YOU Xiuzhen. Predictive value of body mass index and triglyceride level changes in early pregnancy on gestational diabetes mellitus [J]. Laboratory Medicine, 2019, 34(9): 831-834. |
[10] | ZHANG Kainan, ZHANG Zhaoxia. Role of gut microbiota in gestational obesity and diabetes mellitus [J]. Laboratory Medicine, 2019, 34(3): 276-279. |
[11] | JIN Yuewen, YUE Chaoyan, YING Chunmei. Roles of glycated hemoglobin A1c and glycated albumin in screening gestational diabetes mellitus among elderly pregnant women [J]. Laboratory Medicine, 2018, 33(4): 312-315. |
[12] | ZHANG Chunyi, NI Yinghua, JI Xin, YING Chunmei. Correlation of neonate birth weight with glycated hemoglobin A1c and glycated albumin levels in patients with gestational diabetes mellitus [J]. Laboratory Medicine, 2017, 32(3): 165-168. |
[13] | ZHANG Xianghui, ZHAO Yuanming, SUN Zhuoxiang, CHENG Panpan, JIN Chao. Correlation study of serum ferritin and high-sensitivity C reactive protein in gestational diabetes mellitus [J]. Laboratory Medicine, 2015, 30(9): 903-905. |
[14] | KE Huihui, GUO Limei, DING Haiying, XU Yiqun, GU Jiashi, YAN Yuzhong, YANG Xiaoning. The relationships between the serum levels of resistin and insulin resistance among pregnant women with gestational diabetes mellitus in mid-pregnancy [J]. , 2014, 29(9): 921-924. |
[15] | CHENG Chen, ZHANG Yue, HE Jiangtu, XIAO Weifan, GAO Yan, LI Jing, PAN Qiuhui. Significance of glycosylated hemoglobin A1c and glycated albumin for the diagnosis of gestational diabetes mellitus [J]. , 2014, 29(2): 135-138. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||